Crosstalk between T cells and inflamed endothelium: regulation by Crk family proteins

T 细胞和发炎内皮细胞之间的串扰:Crk 家族蛋白的调节

基本信息

  • 批准号:
    9118335
  • 负责人:
  • 金额:
    $ 42万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-08-01 至 2019-04-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Protective immune responses rely on the ability of leukocytes to cross endothelial barriers in response to inflammatory stimuli. However, inflammation is a double-edged sword; immune cells attack healthy tissues in situations such as asthma, rheumatoid arthritis, multiple sclerosis, and transplantation. T cell migration into sites f inflammation is tightly regulated by localized chemokine signals, which activate integrin dependent adhesion and cytoskeletal changes needed for migration across endothelial barriers. Transendothelial migration (TEM) is a multi-step process involving tethering and rolling, firm adhesion, crawling, and finally transmigration. TEM represents an important checkpoint in the inflammatory response, and reagents that block this process are therapeutically valuable. We have found that Crk family proteins function in the chemokine pathway leading to integrin activation and cytoskeletal remodeling, and we find that T cells lacking these proteins have defects in adhesion and TEM. Strikingly, we find that these T cells traffic normally to lymphoid organs, but show defects in migration to sites of inflammation. Moreover, these cells can carry out an efficient graft vs leukemia (GvL) response, with minimal graft vs host disease (GvHD). We hypothesize that Crk proteins are required for chemokine-induced integrin activation and cytoskeletal remodeling in T cells, and for corresponding changes in the endothelium that allow transendothelial migration and T cell trafficking into inflamed tissue. This hypothesis will be tested by carrying out following three Aims: First, we will define the mechanisms through which Crk protein signaling in T cells promotes TEM. Using ligand-coated surfaces and endothelial monolayers under shear flow conditions, we will test the ability of Crk/L deficient T cells to undergo individual steps in the TEM process, and test hypothesis that Crk proteins function through both Rap1 and Cdc42 in this context. Second, we will assess endothelial cell responses to Crk/L-deficient T cells. We will test the hypothesis that defects in Crk-dependent integrin activation within the T cell result in a failure to appropriately activate one or more endothelial ell signaling pathways that are required for efficient TEM. Three pathways that function together to weaken endothelial junctional complexes and generate a specialized conduit for T cell passage will be investigated. Third, we will analyze Crk protein dependent T cell trafficking in acute inflammation and GvHD/GvL models. Consistent with their role in controlling TEM, we find that Crk/L deficient T cells show defects in migration into inflamed tissues. Moreover, these cells cause minimal GvHD, even under conditions where they can efficiently eliminate lymphoma. In this aim, we will use animal models to explore Crk protein function in T cell trafficking during an in vivo immune response. We will conduct histological analysis and intravital imaging to study T cell-vessel interactions in inflamed skin. In addition, we will use GvHD and GvHD/GvL models to study T cell trafficking to target organs, and to test our ability to target Crk protein function i a therapeutic setting.
 描述(由申请人提供):保护性免疫反应依赖于白细胞对炎症刺激的反应跨越内皮屏障的能力。然而,炎症是一把双刃剑;免疫细胞在哮喘、类风湿性关节炎、多发性硬化症和移植等情况下攻击健康组织。T细胞向炎症部位的迁移受到局部趋化因子信号的严格调控,趋化因子信号激活整合素依赖的黏附和细胞骨架变化,这些变化是跨越内皮屏障迁移所需的。跨内皮细胞迁移是一个多步骤的过程,包括系绳和滚动、牢固粘连、爬行和最后的移行。TM代表了炎症反应中的一个重要检查点,而阻断这一过程的试剂具有治疗价值。我们发现Crk家族蛋白在趋化因子途径中发挥作用,导致整合素活化和细胞骨架重塑,我们发现缺乏这些蛋白的T细胞在黏附和透射电子显微镜下存在缺陷。令人惊讶的是,我们发现这些T细胞正常地向淋巴器官运输,但在向炎症部位迁移方面显示出缺陷。此外,这些细胞可以进行有效的移植物抗白血病(GVL)反应,移植物抗宿主病(GvHD)最少。我们假设,Crk蛋白是趋化因子诱导的T细胞整合素激活和细胞骨架重塑所必需的,也是内皮细胞发生相应变化所必需的,从而允许跨内皮细胞迁移和T细胞向炎症组织的运输。这一假说将通过实现以下三个目标来验证:第一,我们将确定T细胞中Crk蛋白信号促进透射电子显微镜的机制。利用剪切流条件下的配体涂层表面和内皮单分子层,我们将测试Crk/L缺陷T细胞在透射电子显微镜过程中经历各个步骤的能力,并验证Crk蛋白在这一背景下通过Rap1和CDc42发挥作用的假设。其次,我们将评估内皮细胞对Crk/L缺陷T细胞的反应。我们将测试这一假设,即T细胞内依赖于Crk的整合素激活缺陷导致未能适当地激活有效的TEM所需的一个或多个内皮细胞信号通路。将研究三种共同作用的途径,它们可以削弱内皮细胞连接复合体,并为T细胞传递产生特殊的管道。第三,我们将分析急性炎症和GvHD/GVL模型中依赖Crk蛋白的T细胞转运。与它们在控制透射电子显微镜中的作用一致,我们发现Crk/L缺陷的T细胞在向炎症组织迁移方面存在缺陷。此外,即使在可以有效消除淋巴瘤的条件下,这些细胞也能最大限度地减少移植物抗宿主病。为此,我们将使用动物模型来探索Crk蛋白在T细胞运输中的作用。 体内免疫反应。我们将进行组织学分析和活体成像,以研究炎症皮肤中T细胞与血管的相互作用。此外,我们将使用GvHD和GvHD/GVL模型来研究T细胞向靶器官的运输,并测试我们在治疗环境中靶向Crk蛋白功能的能力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Janis K. Burkhardt其他文献

Splenic fibroblasts control marginal zone B cell movement and function via two distinct Notch2-dependent regulatory programs
脾成纤维细胞通过两种不同的 Notch2 依赖性调节程序控制边缘区 B 细胞的运动和功能。
  • DOI:
    10.1016/j.immuni.2024.12.003
  • 发表时间:
    2025-01-14
  • 期刊:
  • 影响因子:
    26.300
  • 作者:
    Anneka Allman;Brian T. Gaudette;Samantha Kelly;Nagham Alouche;Léolène J. Carrington;Eric Perkey;Joshua D. Brandstadter;Riley Outen;Ashley Vanderbeck;Katlyn Lederer;Yeqiao Zhou;Robert B. Faryabi;Tanner F. Robertson;Janis K. Burkhardt;Anastasia Tikhonova;Iannis Aifantis;Leonardo Scarpellino;Ute Koch;Freddy Radtke;Mechthild Lütge;Ivan Maillard
  • 通讯作者:
    Ivan Maillard
Stroma-Driven Notch2 Signaling Controls Naïve B Cell Fate By Regulating Microenvironmental Positioning within the Spleen
  • DOI:
    10.1182/blood-2023-186941
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Anneka Allman;Brian Gaudette;Samantha Kelly;Nagham Alouche;Leolene Carrington;Eric Perkey;Riley Outen;Ashley Vanderbeck;Katlyn Lederer;Tanner F. Robertson;Janis K. Burkhardt;Anastasia N. Tikhonova;Iannis Aifantis;Ute Koch;Freddy Radtke;Burkhard Ludewig;Lena Tveriakhina;Achim Gossler;Christian W. Siebel;Daniela Gomez Atria
  • 通讯作者:
    Daniela Gomez Atria

Janis K. Burkhardt的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Janis K. Burkhardt', 18)}}的其他基金

Chemoattractant-specific T cell navigation of complex environments
复杂环境中化学引诱剂特异性 T 细胞导航
  • 批准号:
    10741224
  • 财政年份:
    2023
  • 资助金额:
    $ 42万
  • 项目类别:
Mechanobiology of the immune synapse: signal integration via actin dynamics
免疫突触的力学生物学:通过肌动蛋白动力学进行信号整合
  • 批准号:
    10513815
  • 财政年份:
    2020
  • 资助金额:
    $ 42万
  • 项目类别:
Mechanobiology of the immune synapse: signal integration via actin dynamics
免疫突触的力学生物学:通过肌动蛋白动力学进行信号整合
  • 批准号:
    10307597
  • 财政年份:
    2020
  • 资助金额:
    $ 42万
  • 项目类别:
Modulation of T cell priming by dendritic cell stiffness
树突状细胞硬度调节 T 细胞启动
  • 批准号:
    9369929
  • 财政年份:
    2017
  • 资助金额:
    $ 42万
  • 项目类别:
Costimulatory ligand mobility effects on T cell activation
共刺激配体迁移率对 T 细胞活化的影响
  • 批准号:
    8689121
  • 财政年份:
    2013
  • 资助金额:
    $ 42万
  • 项目类别:
Costimulatory ligand mobility effects on T cell activation
共刺激配体迁移率对 T 细胞激活的影响
  • 批准号:
    8841379
  • 财政年份:
    2013
  • 资助金额:
    $ 42万
  • 项目类别:
Costimulatory ligand mobility effects on T cell activation
共刺激配体迁移率对 T 细胞活化的影响
  • 批准号:
    8431504
  • 财政年份:
    2013
  • 资助金额:
    $ 42万
  • 项目类别:
Cystoskeletal Remodeling During T Cell Activation
T 细胞激活过程中的囊骨骼重塑
  • 批准号:
    7333282
  • 财政年份:
    2007
  • 资助金额:
    $ 42万
  • 项目类别:
University of Pennsylvania Postdoctoral Opportunities in Research and Teaching
宾夕法尼亚大学研究和教学博士后机会
  • 批准号:
    10228016
  • 财政年份:
    2007
  • 资助金额:
    $ 42万
  • 项目类别:
University of Pennsylvania Postdoctoral Opportunities in Research and Teaching
宾夕法尼亚大学研究和教学博士后机会
  • 批准号:
    9981753
  • 财政年份:
    2007
  • 资助金额:
    $ 42万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 42万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 42万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 42万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 42万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了